AI Article Synopsis
- * A case study of a 52-year-old man highlights his long history of treatment-resistant epilepsy, starting with lip twitching at age six and convulsive seizures by age 20.
- * The report details EEG observations showing two unusual seizure patterns: preserved consciousness without absence seizures and instances where lip twitching was tonic instead of the typical myoclonic movements associated with POMA.
Article Abstract
The rare syndrome of perioral myoclonia with absences (POMA) is described as a specific type of idiopathic generalized epilepsy in which absence seizures are accompanied by prominent perioral myoclonus as a consistent symptom. We present a 52-year-old man who was referred to our department due to treatment-resistant epilepsy. Typical seizures were described as rhythmic twitching of the lips which started at six years old, and his first convulsive seizure occurred at around 20 years old. Based on video-EEG recordings, we present two distinct EEG patterns accompanied by slight differences in clinical manifestations, which appear to be atypical of POMA. Firstly, consciousness was preserved during seizures, with no manifestation of absences. Secondly, regarding the EEG features, in some of the seizures, the perioral motor symptoms were tonic rather than myoclonic. The defining features of POMA are discussed in relation to this case.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1684/epd.2018.0978 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Further description of the phenotypic spectrum of neuronal ceroid lipofuscinosis type 11.
Genet Med
January 2025
Dept of Neuromuscular Disease, UCL Institute of Neurology, Queen Sq, London; National Hospital for Neurology and Neurosurgery, Queen Sq, London; National Institute for Health and Care Research (NIHR) and University College London Hospitals, Biomedical Research Centre, London. Electronic address:
Article Synopsis
- The study reports on nine new cases of Ceroid lipofuscinosis type 11 (CLN11) from Latin American families, a rare disease with previously limited documentation.
- Patients showed slow disease progression, with symptoms including visual impairment, seizures, and cognitive decline, starting between ages 3 and 17.
- The findings highlight a potential diagnostic clue for CLN11 and include two specific genetic variants associated with the condition.
Further insights into anti-IgLON5 disease: a case with complex clinical presentation.
BMC Neurol
September 2024
Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Piazzale Brescia 20, Milan, 20149, Italy.
Background: Anti-IgLON5 disease is an autoimmune encephalitis overlapping with neurodegenerative disorders due to pathological accumulation of hyperphosphorylated tau. It is characterized by several clinical manifestations determined by involvement of different brain areas, and mild response to first-line immunotherapies. We report a case of anti-IgLON5 disease with a multifaceted semiology and an unusually good response to glucocorticoid monotherapy.
View Article and Find Full Text PDFGeneralized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance.
Front Neurol
March 2022
Epilepsy Unit, Department of Human Neurosciences, Policlinico "Umberto I", Sapienza University, Rome, Italy.
Objective: To investigate the electroclinical characteristics and the prognostic impact of generalized fast discharges in a large cohort of genetic generalized epilepsy (GGE) patients studied with 24-h prolonged ambulatory electroencephalography (paEEG).
Methods: This retrospective multicenter cohort study included 202 GGE patients. The occurrence of generalized paroxysmal fast activity (GPFA) and generalized polyspike train (GPT) was reviewed.
Unmasking the entity of 'drug-resistant' perioral myoclonia with absences: the twitches, darts and domes!
Epileptic Disord
April 2021
Sree Chitra Tirunal Institute for Medical Sciences and Technology, Dept of Neurology, Thiruvananthapuram, Kerala, India.
Perioral myoclonia with absences (POMA) is not recognized as a unique electro-clinical syndrome and studies suggest its inclusion under the genetic generalized epilepsy (GGE) spectrum. The aim of this study was to explore the prevalence and electro-clinical homogeneity of this disorder in an epilepsy monitoring unit. Between 2013 and 2019, among drug-resistant epilepsy patients who were referred for video-telemetry, those diagnosed with POMA based on the presence of documented absences with prominently observed peri-oral muscular contractions accompanied by generalized EEG features were included.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!